ITMI20040928A1 - Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata - Google Patents
Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminataInfo
- Publication number
- ITMI20040928A1 ITMI20040928A1 IT000928A ITMI20040928A ITMI20040928A1 IT MI20040928 A1 ITMI20040928 A1 IT MI20040928A1 IT 000928 A IT000928 A IT 000928A IT MI20040928 A ITMI20040928 A IT MI20040928A IT MI20040928 A1 ITMI20040928 A1 IT MI20040928A1
- Authority
- IT
- Italy
- Prior art keywords
- procedure
- preparation
- human albumin
- doxorubicin conjugates
- lactosaminated human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000928A ITMI20040928A1 (it) | 2004-05-07 | 2004-05-07 | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata |
| PCT/IT2005/000257 WO2005107814A2 (en) | 2004-05-07 | 2005-05-04 | Process for the preparation of doxorubicin conjugates with lactosaminated human albumin and the obtained conjugates |
| DE602005001947T DE602005001947D1 (de) | 2004-05-07 | 2005-05-04 | Verfahren zur herstellung von doxorubicin-konjugaten mit lactosaminiertem humanalbumin und die erhaltenen konjugate |
| CA002566195A CA2566195A1 (en) | 2004-05-07 | 2005-05-04 | Process for the preparation of doxorubicin conjugates with lactosaminated human albumin and the obtained conjugates |
| US11/579,857 US7528234B2 (en) | 2004-05-07 | 2005-05-04 | Process for the preparation of doxorubicin conjugates with lactosaminated human albumin |
| ES05742724T ES2289710T3 (es) | 2004-05-07 | 2005-05-04 | Proceso para la preparacion de conjugados de doxorubicina con albumina humana lactosaminada y los conjugados obtenidos. |
| EP05742724A EP1753462B1 (en) | 2004-05-07 | 2005-05-04 | Process for the preparation of doxorubicin conjugates with lactosaminated human albumin and the obtained conjugates |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000928A ITMI20040928A1 (it) | 2004-05-07 | 2004-05-07 | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20040928A1 true ITMI20040928A1 (it) | 2004-08-07 |
Family
ID=35320742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000928A ITMI20040928A1 (it) | 2004-05-07 | 2004-05-07 | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7528234B2 (it) |
| EP (1) | EP1753462B1 (it) |
| CA (1) | CA2566195A1 (it) |
| DE (1) | DE602005001947D1 (it) |
| ES (1) | ES2289710T3 (it) |
| IT (1) | ITMI20040928A1 (it) |
| WO (1) | WO2005107814A2 (it) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20051743A1 (it) * | 2005-09-20 | 2007-03-21 | Uni Di Bologna Dipartimento Di Patologia Spa | Uso di coniugati della doxorubicina con albumina lattosaminata |
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| WO2010009271A2 (en) | 2008-07-15 | 2010-01-21 | Academia Sinica | Glycan arrays on ptfe-like aluminum coated glass slides and related methods |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| WO2012167255A1 (en) * | 2011-06-03 | 2012-12-06 | The Regents Of The University Of Colorado, A Body Corporate | Anticancer prodrug therapies |
| MX353608B (es) | 2012-02-24 | 2018-01-19 | Alteogen Inc | Anticuerpo modificado en el que el tema que comprende residuos de cisteina esta ligado, conjugado de farmaco de anticuerpo modificado que comprende el anticuerpo modificado y metodo de produccion para el mismo. |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| JP6302909B2 (ja) | 2012-08-18 | 2018-03-28 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | シアリダーゼの同定および画像化のための細胞透過性プローブ |
| US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
| WO2014210564A1 (en) | 2013-06-27 | 2014-12-31 | Academia Sinica | Glycan conjugates and use thereof |
| CA2923579C (en) | 2013-09-06 | 2023-09-05 | Academia Sinica | Human inkt cell activation using glycolipids with altered glycosyl groups |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| CA2937123A1 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| CN106415244B (zh) | 2014-03-27 | 2020-04-24 | 中央研究院 | 反应性标记化合物及其用途 |
| EP4116329A1 (en) | 2014-05-27 | 2023-01-11 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| TWI717319B (zh) | 2014-05-27 | 2021-02-01 | 中央研究院 | 得自類桿菌屬之岩藻糖苷酶及其用途 |
| EP3149036A4 (en) | 2014-05-27 | 2017-12-27 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| TWI732738B (zh) | 2014-05-28 | 2021-07-11 | 中央研究院 | 抗TNF-α醣抗體及其用途 |
| CA2960712A1 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | Human inkt cell activation using glycolipids |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| CA2972072A1 (en) | 2015-01-24 | 2016-07-28 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| CA3016170A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
| CA3034057A1 (en) | 2016-08-22 | 2018-03-01 | CHO Pharma Inc. | Antibodies, binding fragments, and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2135295A1 (en) | 1992-06-17 | 1993-12-23 | Chu Jung | Arabinogalactan derivatives and uses thereof |
| BRPI0606395A2 (pt) | 2005-01-05 | 2009-06-23 | Univ Texas | conjugados para ambas imagem e radioquimioterapia: composição, fabricação e aplicações |
| ITMI20051743A1 (it) | 2005-09-20 | 2007-03-21 | Uni Di Bologna Dipartimento Di Patologia Spa | Uso di coniugati della doxorubicina con albumina lattosaminata |
-
2004
- 2004-05-07 IT IT000928A patent/ITMI20040928A1/it unknown
-
2005
- 2005-05-04 DE DE602005001947T patent/DE602005001947D1/de active Active
- 2005-05-04 CA CA002566195A patent/CA2566195A1/en not_active Abandoned
- 2005-05-04 US US11/579,857 patent/US7528234B2/en not_active Expired - Fee Related
- 2005-05-04 ES ES05742724T patent/ES2289710T3/es active Active
- 2005-05-04 WO PCT/IT2005/000257 patent/WO2005107814A2/en active IP Right Grant
- 2005-05-04 EP EP05742724A patent/EP1753462B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005107814A3 (en) | 2006-02-23 |
| EP1753462B1 (en) | 2007-08-08 |
| US7528234B2 (en) | 2009-05-05 |
| US20070219351A1 (en) | 2007-09-20 |
| ES2289710T3 (es) | 2008-02-01 |
| DE602005001947D1 (de) | 2007-09-20 |
| EP1753462A2 (en) | 2007-02-21 |
| WO2005107814A2 (en) | 2005-11-17 |
| CA2566195A1 (en) | 2005-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI20040928A1 (it) | Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata | |
| IL177847A0 (en) | Use of lipid conjugates in the treatment of disease | |
| ATE465758T1 (de) | Ivermectin enthaltende creme | |
| IL150628A0 (en) | Use of lipid conjugates in the treatment of disease | |
| DE602004026768D1 (de) | Therapeutische anti-igfr1-antikörper-kombinationen | |
| ATE480567T1 (de) | Hochkonzentrierter antikörper und proteinformulierungen | |
| DE602005020912D1 (de) | Ivermectin enthaltende creme | |
| DE60237307D1 (de) | Einstellbare herz-resynchronisation | |
| NO20041802L (no) | Antistoffer mot human vevsfaktor | |
| DE50104287D1 (de) | Verbundkörper | |
| IL212215A0 (en) | Use of lipid conjugates in the treatment of disease | |
| DE602004016877D1 (de) | Untersuchungsstuhl | |
| DE60203537D1 (de) | 5ht1-rezeptoragonist enthaltendes arzneimittel | |
| DE60222900D1 (de) | Uv-abschirmende peptid-flavonoid konjugate | |
| ATE513564T1 (de) | Immunogener rekombinanter antikörper | |
| ITMI20000050A0 (it) | Procedimento per la preparazione della 5-carbossiftalide | |
| ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
| FI20030664A (fi) | In vivo -kuvantaminen käyttäen peptidijohdannaisia | |
| EP1341802A4 (en) | IN-VITROPROTEIN SYNTHESIS USING GLYCOLYTIC INTERMEDIATE PRODUCTS AS AN ENERGY SOURCE | |
| GB0418893D0 (en) | Use of rhodiola crenulata extract via the topical route | |
| ITMI20042099A1 (it) | Estratti di trifoglio per la preparazione di agenti anti-afidi | |
| DE50306757D1 (de) | Zubereitungen zur oralen Aufnahme | |
| ITMI20041086A1 (it) | Procedimento per la preparazione di idrocarbilalogenuri | |
| IL229980A0 (en) | Use of fatty conjugates to treat diseases | |
| IL229981A0 (en) | Use of fatty conjugates to treat diseases |